Inventor
ZHENGGANG ZHAO
Inventor
CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes20%
C12NMicroorganisms or enzymes13%
C12YEnzymes13%
C07BGeneral methods of organic chemistry7%
C07DHeterocyclic compounds7%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms7%
Y02ATechnologies for adaptation to climate change7%
PatentTitleYear
12,569,484Use of phosphodiesterase 5 inhibitor in preparation of medicament for resisting fibrotic diseases202612,478,664Use of genetically engineered strain VNP20009-M in preventing and treating cancer metastasis202512,441,732Potassium salt crystal form B of phosphodiesterase type 5 inhibitor, and preparation method and use therefor202511,318,172Use of genetically engineered bacterium of attenuated 2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to GUANGZHOU SINOGEN PHARMACEUTICAL CO LTD (2)· patent assignee history
2022–2026Based in CN· patent location history
2025–2026Patents assigned to SHENZHEN HANHUI PHARMACEUTICAL TECH CO LTD (2)· patent assignee history
2025Patents assigned to GUANGZHOU HUAZHEN PHARMACEUTICAL CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GUANGZHOU SINOGEN PHARMACEUTICAL CO LTD | 2 | 2022–2025 |
| SHENZHEN HANHUI PHARMACEUTICAL TECH CO LTD | 2 | 2025–2026 |
| GUANGZHOU HUAZHEN PHARMACEUTICAL CO LTD | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 4 | 2022–2026 |